In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1852 News Items found
Vice President Joe Biden.
In the News
#ASCO16 Highlights: Treating Cancer in the Older Patient, a Visit from VP Biden, and More

In case you missed it, here’s a recap of Monday’s highlights from the American Society of Clinical Oncology annual meeting.
Two cancer researchers at the American Society of Clinical Oncology annual meeting
In the News
#ASCO16 Highlights: A "Smart-Bomb" for Lung Cancer, Bladder Cancer Advances, and More

Couldn’t be at ASCO this year? Read highlights from the first half of the meeting.
A woman who is exercising checks her heart rate.
In the Lab
Women with Early Breast Cancer Can Ward Off Heart Problems with Exercise

Discover how exercise can reduce the long-term risk of cardiovascular disease in women with early-stage breast cancer.
Q&A
Combination Immunotherapy Shows New Promise for Lung Cancer

Results to be presented at the upcoming American Society of Clinical Oncology (ASCO) meeting suggest combination immunotherapy may help more people with the most common form of lung cancer.
Vice President Joe Biden led a roundtable “cancer moonshot” discussion at Memorial Sloan Kettering
In the News
Between the Moon and New York City: Vice President Biden Leads MSK Cancer Moonshot Roundtable

Find out what Vice President Joe Biden had to say when he visited MSK for a roundtable “cancer moonshot” discussion.
Memorial Sloan Kettering Cancer Center Hosts Roundtable Discussion with Vice President Biden and Leaders of the Cancer Community

Vice President Joseph Biden visited Memorial Sloan Kettering Cancer Center (MSK) for a roundtable discussion with MSK experts and members of the cancer community. The candid conversation, inspired by the “moonshot” initiative announced by President Obama, was led by Craig Thompson, MD, President and CEO of MSK. MSK’s Carol Brown, MD, Ross Levine, MD, and Robert Sidlow, MD, were also active participants in the discussion. For more information about the event or to request an interview with a MSK roundtable participant, please e-mail [email protected].
Despite Pressing Need, Memorial Sloan Kettering Survey Finds Most Americans Unlikely to Enroll in Clinical Trials

The lack of participation in clinical research may be the Achilles heel facing today’s cancer community. According to a new survey of more than 1,500 consumers and nearly 600 physicians conducted on behalf of MSK, only 35 percent of Americans indicated that they were “likely” to enroll in a clinical trial. For more information or to schedule an interview, please contact [email protected].
A young female doctor in a white coat sits with an older male patient in an exam room
Finding
Uncertainties about Clinical Trials Keep Patients from Enrolling

Most people are aware of how important clinical trials for cancer are and how they can lead to lifesaving breakthroughs, but they’re also unlikely to participate in them.
A Hodgkin lymphoma survivor who received nivolumab as part of a clinical trial.
In the Clinic
Immunotherapy Drug Approved for Treatment of Hodgkin Lymphoma

The immunotherapy drug nivolumab is now approved for patients whose Hodgkin lymphoma has failed other treatments.
DNA molecules wrapped around histones
Feature
The Future of Cancer Research: Five Reasons for Optimism

Discover some of the most exciting research that Memorial Sloan Kettering scientists are pursuing in the fight against cancer.